ALLERGOSPASMIN N

This brand name is authorized in Germany

Active ingredients

The drug ALLERGOSPASMIN N contains a combination of these active pharmaceutical ingredients (APIs):

1 Sodium cromoglicate
UNII Q2WXR1I0PK - CROMOLYN SODIUM

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.

Read about Cromoglicic acid
2 Reproterol
UNII Y4I1COJ8W8 - REPROTEROL HYDROCHLORIDE
Read about Reproterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AK05 Reproterol and other drugs for obstructive airway diseases R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut fĂźr Arzneimittel und Medizinprodukte Identifier(s): 00585012, 00585029, 00585035

Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈